Pathogenic variants of BRCA1, BRCA2, MLH1, MSH2, MSH6, PALB2, CHEK2, ATM, and TP53 were associated with an increased risk of breast and colorectal cancer [4,22,23]. Here, TP53 is linked to colorectal cancer.